Jinjunling Capsules for chronic hepatitis adjuvant therapy
ACTIONS
Tonifying qi and blood,strengthening and consolidating body resistance.
INDICATIONS
For tumors, chronic hepatitis adjuvant therapy.
INGREDIENTS
Flammlina velutipes mycelium.
PROPERTIES
Capsules,brown,yellow powder inside,light salty.
Spec.
0.25g*36 capsules/box.
USAGE AND DOSAGE
Oral,4 capsules per time,twice daily.
ADVERSE REACTION
Not known.
CONSTRAINDICATION
Not known.
PRECAUTION
Not known.
DRUG INTERACTIONS
If use with the other drugs at the same time may occur drug interactions,details please consult your physician or pharmacist.
VALIDITY
36 months.
STORAGE
Preserve in tightly closed containers,stored in a cool and dry place.
APPROVAL NUMBER
State medical permitment number.Z37020643.
Manufactured
YANTAI DONGCHENG DAYANG PHARMACEUTICAL CO.,LTD
EXECUTION STANDARD
National Drug Standard WS3-B1759-94-2002.
General Cautions:
Keep away from animals and children.
This product has not been evaluated by the FDA. It is not intended to
diagnose, treat, cure, or prevent any disease.
We highly recommend that you consult with a Traditional Chinese Medical
practitioner or physician before taking any products or if you have any questions regarding your health.
Tips: part of the goods frequent replacement of packaging, sometimes goods and pictures are not exactly the same, please refer to the goods you receive.
